D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.67% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UCFI
2951
CN Healthy Food Tech Group
UCFI
| $1.22M | ﹤0.01% |
119,035
| – | – |
|
2952
STAAR Surgical
STAA
$1.13B
| $1.22M | ﹤0.01% |
+50,249
| New | +$1.43M |
|
2953
Telefônica Brasil
VIV
$19.5B
| $1.22M | ﹤0.01% |
161,549
+146,371
| +964% | +$1.3M |
|
|
RAPT
2954
DELISTED
RAPT Therapeutics
RAPT
| $1.22M | ﹤0.01% |
96,252
-34,771
| -27% | -$442K |
|
|
GPMT
2955
Granite Point Mortgage Trust
GPMT
$61.3M
| $1.21M | ﹤0.01% |
433,991
-134,940
| -24% | -$425K |
|
|
ALTM
2956
PUT
DELISTED
Arcadium Lithium plc
ALTM
| $1.21M | ﹤0.01% |
235,680
| – | – |
|
2957
MBIA
MBI
$270M
| $1.21M | ﹤0.01% |
186,828
-38,051
| -17% | -$196K |
|
2958
Tyson Foods
TSN
$20.5B
| $1.2M | ﹤0.01% |
+20,942
| New | +$1.27M |
|
2959
Strategic Education
STRA
$1.83B
| $1.2M | ﹤0.01% |
12,869
-13,718
| -52% | -$1.28M |
|
2960
PUT
Chemours
CC
$2.32B
| $1.2M | ﹤0.01% |
70,900
+50,400
| +246% | +$981K |
|
2961
Aurinia Pharmaceuticals
AUPH
$2.07B
| $1.2M | ﹤0.01% |
133,333
+39,384
| +42% | +$321K |
|
2962
CALL
Uranium Energy
UEC
$5.34B
| $1.19M | ﹤0.01% |
+178,100
| New | +$1.36M |
|
2963
Marcus Corp
MCS
$947M
| $1.19M | ﹤0.01% |
55,398
+8,267
| +18% | +$164K |
|
2964
Healthcare Realty
HR
$6.95B
| $1.19M | ﹤0.01% |
70,260
-571,953
| -89% | -$10.1M |
|
2965
3D Systems Corp
DDD
$603M
| $1.19M | ﹤0.01% |
362,978
+79,192
| +28% | +$252K |
|
2966
Independent Bank
INDB
$4.03B
| $1.19M | ﹤0.01% |
18,521
-96,785
| -84% | -$6.45M |
|
2967
Ingevity
NGVT
$2.68B
| $1.19M | ﹤0.01% |
29,150
-64,747
| -69% | -$2.7M |
|
2968
PUT
Camtek
CAMT
$7.12B
| $1.19M | ﹤0.01% |
14,700
+4,200
| +40% | +$330K |
|
2969
CALL
Prudential Financial
PRU
$41.8B
| $1.19M | ﹤0.01% |
10,000
| – | – |
|
2970
PUT
Cardinal Health
CAH
$55.1B
| $1.18M | ﹤0.01% |
10,000
| – | – |
|
2971
iShare MSCI Eurozone ETF
EZU
$9.85B
| $1.18M | ﹤0.01% |
25,035
+2,474
| +11% | +$121K |
|
2972
Tiptree Inc
TIPT
$666M
| $1.18M | ﹤0.01% |
56,592
+10,764
| +23% | +$225K |
|
2973
Sasol
SSL
$7.24B
| $1.18M | ﹤0.01% |
258,800
+168,030
| +185% | +$950K |
|
2974
Semtech
SMTC
$12.5B
| $1.18M | ﹤0.01% |
+19,010
| New | +$1M |
|
2975
Smith Douglas Homes
SDHC
$116M
| $1.17M | ﹤0.01% |
45,724
-8,278
| -15% | -$275K |
|
Similar funds
D.E. Shaw & Co's Q4 2024 Portfolio in Review
As of Q4 2024, D.E. Shaw & Co held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- D.E. Shaw & Co's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- D.E. Shaw & Co's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- D.E. Shaw & Co fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- D.E. Shaw & Co opened 591 new positions and closed 731 in Q4 2024.
- D.E. Shaw & Co's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.